Pulse Biosciences Stock - weekly review and sector comparison
19.06.2026 - 16:33:10 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 16:32 CET. Details in the imprint.
Pulse Biosciences (US73242P1030) stock is ending the week with investors reassessing its cash position and niche in energy-based medical devices. With no fresh company news on Friday, the focus turns to its recent trading pattern and how it stacks up against peers.
All news and background on Pulse Biosciences stock
Current and past coverage of Pulse Biosciences stock, company filings and market data can be found in the dedicated topic area and on the company’s investor-relations page.
How Pulse Biosciences stock has traded lately
Pulse Biosciences shares trade on the Nasdaq under the ticker "PLSE" and are part of a small-cap group of US-listed medical device names focused on aesthetic and dermatologic applications. Recent trading volumes remain relatively modest compared with large-cap medtech peers.
Market data show that the stock has been volatile over the past 12 months, consistent with other early-stage medical technology companies without recurring profitability. The share price has periodically reacted to clinical and regulatory milestones as well as financing updates.
Weekly review and peer-group comparison
Against the backdrop of a calmer broader market, the weekly review for Pulse Biosciences centers less on fresh headlines and more on positioning relative to sector peers in energy-based aesthetic and dermatology devices. Comparable groups include smaller US-listed device developers with a focus on skin and cosmetic indications.
These companies generally share features such as high research and development spending, concentrated product portfolios and sensitivity to capital-market conditions. On balance, Pulse Biosciences fits this pattern, with investor attention often tied to progress in technology adoption and any updates on commercial rollouts.
What the company sells
Pulse Biosciences focuses on pulsed electric field-based medical technologies designed for dermatologic and aesthetic procedures. Its business model centers on developing device platforms and accessories that can be used by physicians in clinical and cosmetic settings with a recurring component from consumables.
Where the stock trades today
The shares of Pulse Biosciences (US73242P1030) trade on the Nasdaq at $8.50 as of 06/19/2026, 16:32 CET.
Key facts on Pulse Biosciences stock
- Company: Pulse Biosciences Inc.
- ISIN: US73242P1030
- WKN: A2DYSB
- Ticker: PLSE
- Venue: Nasdaq
- Price (as of 06/19/2026, 16:32 CET): 8.50 USD
- Market cap: 350,000,000 USD (as of 06/19/2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: not a member of major headline indices such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
